I am involved in translational research into malaria and other parasitic infectious diseases with the ultimate goal of applying genomic research output to inform malaria control and elimination. My research revolves around understanding the role of human and parasite genetic variations in infectious diseases. These involve human genetic predisposition to infectious diseases such as malaria, pathogen drug resistance and virulence. The major focus of my work is studying human genomics to understand disease associations with immune response genes. The interaction between hemoglobinopathies such as sickle cell disease/trait and malaria pathogenicity has also been a long-standing research interest. I also focus on how genetic variation influence the epidemiology and pathogenicity of malaria and its implication on therapeutic and vaccination strategies and malaria control in general. In addition I have a keen interest in using population genetics strategies to identify genetic loci that contribute to drug resistance in P. falciparum and the development of genomic tools to characterize P. falciparum diversity in the population. I am also Exploring Plasmodium falciparum genome to understand the genetic diversity, emergence of drug resistance and vaccine efficacy. I also apply the genetic/genomics skills to understand genetic predisposition to chronic kidney diseases. To effectively harness the large sequence data being generated, I have also been involved in bioinformatics training.
I am involved in translational research into malaria and other parasitic infectious diseases with the ultimate goal of applying genomic research output to inform malaria control and elimination. My research revolves around understanding the role of human and parasite genetic variations in infectious diseases. These involve human genetic predisposition to infectious diseases such as malaria, pathogen drug resistance and virulence. The major focus of my work is studying human genomics to understand disease associations with immune response genes. The interaction between hemoglobinopathies such as sickle cell disease/trait and malaria pathogenicity has also been a long-standing research interest. I also focus on how genetic variation influence the epidemiology and pathogenicity of malaria and its implication on therapeutic and vaccination strategies and malaria control in general. In addition I have a keen interest in using population genetics strategies to identify genetic loci that contribute to drug resistance in P. falciparum and the development of genomic tools to characterize P. falciparum diversity in the population. I am also Exploring Plasmodium falciparum genome to understand the genetic diversity, emergence of drug resistance and vaccine efficacy. I also apply the genetic/genomics skills to understand genetic predisposition to chronic kidney diseases. To effectively harness the large sequence data being generated, I have also been involved in bioinformatics training.